Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | N. Golob-Schwarzl et al., Oncotarget, 2017, 8(60): 101224-101243 | Link | |
M14 |
Human metastatic melanoma cells | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene SI | publication | A. Sarma et al., The American J. of Pathology, 2021, 191, 2, doi.org/10.1016/j.ajpath.2020.10.015 | Link | ||
M14 |
Human metastatic melanoma cells | Human | skin | cell line | adherent | plasmid | CRISPR | Metafectene SI | publication | A. Sarma et al., The American J. of Pathology, 2021, 191, 2, doi.org/10.1016/j.ajpath.2020.10.015 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. De Luca et al., Scientific Reports, 2021, 11: 4615, doi.org/10.1038/s41598-021-84222- | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | miRNA | Metafectene SI | application note | ![]() |
|||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | J.-E. Lee et al., Journal of Proteomics, 2016, 131: 17-28; doi.org/10.1016/j.jprot.2015.10.005 | ||
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., SpringerPlus, 2016, 5:156; DOI 10.1186/s40064-016-1768-6 | Link | |
Mz-ChA-2 |
Human extrahepatic biliary tract gallbladder carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | N. Golob‑Schwarzl et al., J. of Cancer Res. and Clin. Oncology, 2019, 145: 2699–2711, doi.org/10.1007/s00432-019-03030-x | Link | ||
NCI-H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | X. Zhou et al., J. Biol. Chem., Jul 2013; 288: 21793 - 21801 | Link | |
NCI-H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. Margiotta et al., Biochim. et Biophys. Acta, 2017, 1864: 367-381; doi.org/10.1016/j.bbamcr.2016.11.020 | ||
NCI-H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. Margiotta et al., Biochimica et Biophysica Acta, 2017, 1864: 367-381 | ||
NCI-H441 |
Human lung papillary adenocarcinoma cell line | ATCC HTB-174 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. M. Usmani et al., Cell. Microbiology, 2012, 14(3): 299–315, doi:10.1111/j.1462-5822.2011.01724.x | Link | |
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Cogoi et al., Nucleic Acids Res., Apr 2013; 41: 4049 - 4064 | Link | |
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. D. Konitsiotis et al., PLoS ONE, 2014, 9(3): e89899, doi:10.1371/journal.pone.0089899 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., BMC Cancer, 2014, 14:921, doi:10.1186/1471-2407-14-921 | Link | |
PEC |
Human primary conjunctival cells | Human | sensory organs | primary cell | adherent | miRNA | Metafectene SI | publication | Q. Pilson et al., Scientific Reports, 2020, 10: 7484, doi.org/10.1038/s41598-020-64422-5 | Link | |||
Phoenix |
Retrovirus producer cell line (Derivat of 293T) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Dossena et al., J. Biol. Chem., Nov 2011; 286: 40659 - 40670 | Link | ||
Phoenix |
Retrovirus producer cell line (Derivat of 293T) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | E. Bernardinelli et al., PLOSONE, doi.org/10.1371/journal.pone.0179591 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | F. Albano et al., Biochimie, 2012, DOI: 10.1016/j.biochi.2012.12.012 | |||
SAOS-2 |
Human bone osteosarcoma cell line | ATCC HTB-85 | Human | bone | cell line | adherent | siRNA | Metafectene SI | publication | X. Zhou et al., Cell Death and Differentiation, 2015, 22:755-766; doi:10.1038/cdd.2014.167 | Link | ||
SAS |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Xu et al., PLoS ONE, 2015, 10(3):e0121439; doi:10.1371/journal.pone.0121439 | Link | ||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | H. Guan et al., Experimental Neurology, 2017, 291: 51-61 | Link | |
T-24 |
Human urinary bladder cancer cell line | ATCC HTB-4 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | C. Amantini et al., Oncotarget, 2016, 7(31): 50180-50194 | Link | |
T98 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., Oncotarget, 2016, 7 (28): 43654-43668 | Link | ||
TCA8113 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Xu et al., PLoS ONE, 2015, 10(3):e0121439; doi:10.1371/journal.pone.0121439 | Link |